Patents by Inventor Marco Forzatti

Marco Forzatti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline beta-lactamase inhibitor
    Patent number: 11124526
    Abstract: A crystalline compound of formula (I): The compound of formula (I) is a ?-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: September 21, 2021
    Assignee: Allecra Therapeutics SAS
    Inventors: Alessandro Lamonica, Marco Forzatti, Stefano Biondi
  • CRYSTALLINE BETA-LACTAMASE INHIBITOR
    Publication number: 20190071456
    Abstract: A crystalline compound of formula (I): The compound of formula (I) is a ?-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.
    Type: Application
    Filed: October 31, 2018
    Publication date: March 7, 2019
    Applicant: Allecra Therapeutics SAS
    Inventors: Alessandro Lamonica, Marco Forzatti, Stefano Biondi
  • Method of forming methyl penam derivatives
    Patent number: 9963465
    Abstract: A method of forming a compound of formula (IIIa): wherein: R1 in each occurrence is independently selected from H, halogen, amino, C1-5 alkyl, C1-5 alkenyl and C1-5 alkynyl; R2 in each occurrence is independently selected from H, halogen, amino, C1-5 alkyl, C1-5 alkenyl and C1-5 alkynyl; R4 is C1-5 alkyl; and R6 is a C1-5 fluoroalkyl; and PG is a protecting group, the method comprising the step of reacting a compound of formula (IIa) with a compound of formula (VIII):
    Type: Grant
    Filed: May 14, 2015
    Date of Patent: May 8, 2018
    Assignee: Allecra Therapeutics SAS
    Inventors: Andrea Faini, Marco Forzatti, Giovanni Fogliato, Stefano Biondi
  • METHOD
    Publication number: 20170101421
    Abstract: A method of forming a compound of formula (IIIa): wherein: R1 in each occurrence is independently selected from H, halogen, amino, C1-5 alkyl, C1-5 alkenyl and C1-5 alkynyl; R2 in each occurrence is independently selected from H, halogen, amino, C1-5 alkyl, C1-5 alkenyl and C1-5 alkynyl; R4 is C1-5 alkyl; and R6 is a C1-5 fluoroalkyl; and PG is a protecting group, the method comprising the step of reacting a compound of formula (IIa) with a compound of formula (VIII):
    Type: Application
    Filed: May 14, 2015
    Publication date: April 13, 2017
    Applicant: Allecra Therapeutics SAS
    Inventors: Andrea Faini, Marco Forzatti, Giovanni Fogliato, Stefano Biondi
  • Crystalline Beta-Lactamase Inhibitor
    Publication number: 20160289245
    Abstract: A crystalline compound of formula (I): The compound of formula (I) is a ?-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 6, 2016
    Applicant: Allecra Therapeutics SAS
    Inventors: Alessandro Lamonica, Marco Forzatti, Stefano Biondi
  • Purification of beta-lactam products
    Patent number: 7728126
    Abstract: Method for purifying 7?-methoxy-cephalosporins containing as impurity the corresponding 7?-methylthio analogue, which is transformed into its methoxy analogue by treatment with a halogenating agent in methanol. In this way the complete conversion of the sulphurated impurity into the corresponding methoxy analogue is obtained.
    Type: Grant
    Filed: August 17, 2006
    Date of Patent: June 1, 2010
    Assignee: ACS DOBFAR S.p.A.
    Inventors: Giovanni Fogliato, Marco Forzatti, Maurizio Zenoni
  • PURIFICATION OF BETA-LACTAM PRODUCTS
    Publication number: 20070093657
    Abstract: Method for purifying 7?-methoxy-cephalosporins containing as impurity the corresponding 7?-methylthio analogue, which is transformed into its methoxy analogue by treatment with a halogenating agent in methanol. In this way the complete conversion of the sulphurated impurity into the corresponding methoxy analogue is obtained.
    Type: Application
    Filed: August 17, 2006
    Publication date: April 26, 2007
    Applicant: ACS DOBFAR S.p.A.
    Inventors: Giovanni FOGLIATO, Marco Forzatti, Maurizio Zenoni